Results 91 to 100 of about 23,919 (200)

Aztreonam Acts as a Synergist for Ceftazidime/Avibactam Against Carbapenem-Resistant Enterobacteriaceae (CRE) of Various Carbapenemase Phenotypes in Southwestern China [PDF]

open access: yes
Xuelian Ruan,1,* Zhiyu Gong,1,* Moqiyi Zeng,1 Ziqing Zhong,1 Yongling Chen,1 Fangyi Wei,1 Chong Lei,1 Yuanyuan Zhu,1 Xue Qin,1 Meng Li1,2 1Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key
Ruan X   +9 more
core   +1 more source

Contributions and Evolutionary Potential of ampC Mutations to confer Aztreonam Resistance in Pseudomonas aeruginosa [PDF]

open access: yes, 2019
Thesis (Master's)--University of Washington, 2019Aztreonam is a synthetic monobactam antibiotic that is increasingly used for chronic suppressive therapy in Cystic Fibrosis (CF) patients with Pseudomonas aeruginosa airway infection. P.
Lee, Duan-kun
core  

Activities of aztreonam in combination with several novel β-lactam-β-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae strains coproducing KPC and NDM

open access: yesFrontiers in Microbiology
Isolates coproducing serine/metallo-carbapenems are a serious emerging public health threat, given their rapid dissemination and the limited number of treatment options.
Xinhui Li   +9 more
doaj   +1 more source

DEVELOPMENT AND VALIDATION OF AN ECOLOGICAL, NEW AND RAPID STABILITY-INDICATING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY FOR QUANTITATIVE DETERMINATION OF AZTREONAM IN LYOPHILIZED POWDER FOR INJECTION

open access: yesDrug Analytical Research, 2017
Aztreonam is a monocyclic synthetic antimicrobial with bactericidal activity against Gram-negative bacteria, the first agent from the monobactam family to be therapeutically approved.
Andressa Leme Figueiredo   +2 more
doaj   +1 more source

Characterizing Aztreonam Resistance in Pseudomonas aeruginosa through Artificial Selection and Whole Genome Sequencing [PDF]

open access: yes, 2017
Thesis (Master's)--University of Washington, 2017-06While much attention has been focused on acquired antibiotic resistance genes, chromosomal mutations may be most important in chronic infections where isolated, persistently infecting lineages ...
McLean, Kathryn Ann
core  

Data_Sheet_2_Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumannii.xlsx [PDF]

open access: yes, 2018
Background: Polymyxins are a last-line class of antibiotics against multidrug-resistant Acinetobacter baumannii; however, polymyxin resistance can emerge with monotherapy.
Xiaofen Liu (286972)   +10 more
core   +1 more source

7-O-Carboxylic Acid-Substituted 3-O-Alkyl Difluoroquercetin; An Aztreonam-Potentiating Agent Against Carbapenemase-Producing Pseudomonas aeruginosa Through Simultaneous Inhibition of Metallo-β-Lactamase and Efflux Pump

open access: yesAntibiotics
Background/Objectives: Previously, we reported that 3-O-alkyl difluoroquercetins (di-F-Q) potentiates the antimicrobial activity of aztreonam (ATM) against metallo-β-lactamase (MBL)-producing P.
Seongyeon Lee   +6 more
doaj   +1 more source

Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report [PDF]

open access: yes, 2017
Aztreonam, a broad-spectrum monobactam, is typically reserved for multidrug resistant (MDR) infections. Pharmacokinetic (PK) data to guide dosing in children, however, are limited to healthy volunteers or nonintensive care unit (ICU) patients.
Wayne S. Moore   +3 more
core   +1 more source

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]

open access: yesInfection and Drug Resistance, 2021
Tan X, Kim HS, Baugh K, et al. Infect Drug Resist.2021;14:125–142.  Page 134, left column, second paragraph, fourth sentence from the bottom, the text “Generally, all four tetracyclines have higher tissue concentrations than ...
Tan X   +8 more
doaj  

Is Inappropriate Documentation of Penicillin Allergy Related to Overuse of Aztreonam? [PDF]

open access: yes, 2019
Background: Penicillin allergy is one of the most common drug allergies, with a 10% prevalence in the United States. Only 10% of patients who self-report a penicillin allergy will react if given penicillin, and only 1% will experience an Immunoglobulin E
Adefisoye, James   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy